Hieber's Pharmacy, Pittsburgh, PA

Is Hieber's Pharmacy registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does Hieber's Pharmacy hold a Pennsylvania pharmacy license?

State board of pharmacy records for Pennsylvania are not checked: the Department of State’s license lookup (PALS) did not respond on November 6, 2026, and when tried again on November 7, 2026 it answered with a script-driven search application, which this index does not use; its monthly discipline reports are listed only through a script-driven search page.

Has Hieber's Pharmacy had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter close-out (May 1, 2020), 1 state handoff letter (May 1, 2020) and 1 FMD-145 letter (May 1, 2020) for Hieber's Pharmacy. State board of pharmacy records for Pennsylvania are not checked: the Department of State’s license lookup (PALS) did not respond on November 6, 2026, and when tried again on November 7, 2026 it answered with a script-driven search application, which this index does not use; its monthly discipline reports are listed only through a script-driven search page. The state referral and handoff letters above are FDA’s letters to the state, not board actions.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
Hieber's Pharmacy
Location
Pittsburgh, PA
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
1
Warning letters on FDA’s actions page
0
Latest action on that page
May 1, 2020
FDA Data Dashboard inspections
No matching site found
Form 483 text on this page
1 Form 483, 1 observation
State board records
Not checked

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Hieber's Pharmacy, a 503A facility, with 4 dated actions.

Document
May 1, 2020State handoff letterState Handoff Letter Issued 05/01/2020Not linked by FDA
May 1, 2020Warning letter close-outWarning Letter Close Out Issued 05/01/2020Not linked by FDA
May 1, 2020FMD-145 letterFMD-145 Letter Issued 05/01/2020FDA copy (archived)
Jul 17, 2019Form 483483 Issued 07/17/2019fda.gov

A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.

FDA inspection classifications and published Form 483s

No inspected site under this exact name and city was found in the FDA Data Dashboard on Nov 15, 2026, searching 12,593 US sites with a drug inspection ending Oct 1, 2008 to Oct 23, 2026. FDA may list the site under another legal name, so this is not a finding that it was never inspected.

Form 483 observations

A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.

FDA’s published Form 483 for this site has 1 numbered observation in all. Each observation is quoted from the PDF as FDA numbered it. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.

Inspection Jul 8, 2019 to Jul 17, 2019: 1 observation

Firm on the cover
Hieber's Pharmacy, DRESS 3 500 5T H Avenue; Suite 100, Pittsburgh, PA 15213-3337 TYPE ESTABLI SHMENT IN SPEC TED Producer o f Ste rile and Non-sterile drug products
FEI number
1000214199
FDA district office on the cover
OS Customhouse Rm900 200 Chestnut St Philadelphia, PA 19106
Matched to this page by
firm name, city and state on the cover; linked from actions page
FDA document
Read the full 483 (PDF on fda.gov)

Observation 1

Procedures designed to identify and prevent insanitary conditions are not established and followed by your firm.

Specifically,

Your firm did not perform appropriate environmental monitoring in your aseptic processing areas. For example, pressure differentials between areas with different air classifications were not monitored before or during sterile drug production.

The air pressure differential between the ISO 5 <Redacted B4> and the ISO 7 clean room is not monitored. Instead personnel perform a <Redacted B4> visual inspection of the pressures on the and the clean room gauge, and record the pressures on the Cleaning and Calibration Log. Additionally, there is no pressure gauge to monitor the pressure or pressure differential between the ISO 7 clean room and the uncontrolled environment in the vestibule.

This is a repeat observation from the 2017 inspection.

State board of pharmacy records

State board of pharmacy records for Pennsylvania are not checked: the Department of State’s license lookup (PALS) did not respond on November 6, 2026, and when tried again on November 7, 2026 it answered with a script-driven search application, which this index does not use; its monthly discipline reports are listed only through a script-driven search page.

This page restates FDA’s lists. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.